Anteotech Ltd · ASX:ADO
Anteotech — Anteo Diagnostics — Investor Presentation (November 2017)
58 slides from Anteotech's investor presentation, Nov 6, 2017
Slide 1: Webinar November 6th 2017
For personal use only Webinar November 6th 2017 Dr. John Hurrell, Chairman, Anteo Diagnostics
Slide 2: Disclaimer
Disclaimer For personal use only The purpose of the presentation is to provide an update of the business of Anteo Diagnostics (ASX:ADO). These slides have been prepared as a presentation aid only and the information they contain may require further explanation and/or clarification. Accordingly, thes
Slide 3: Agenda
AGENDA For personal use only 1. Challenges & Outcomes 2. Strategy and Goals of the Company 3. Board Structure 4. Update on Opportunities 5. Summary 3
Slide 4: Synopsis
Synopsis For personal use only o Anteo has been through a difficult period but has survived with cash in the bank and a bright future o The company has initiated major initiatives in order to create STABILITY so that the company can focus on the important issues of leveraging our IP to grow the valu
Slide 5: Challenges and Outcomes
For personal use only Challenges and Outcomes 5
Slide 6: Challenges
Challenges For personal use only Over the past 12 months the company has been in survival mode. Issues facing the company over this period have been: o Limited and dwindling cash o Looming financial obligations to the Vendors o Downward pressure on the share price o Board and Management instability
Slide 7: Outcomes
Outcomes For personal use only o A loan from a few Shareholders, Directors and Management extended the cash runway until a solution was achieved o Discussions were unsuccessfully held with two potential merger candidates o Approximately 50 companies were identified and discussions held regarding pur
Slide 8: Strategy and Goals
For personal use only Strategy and Goals 8
Slide 9: Our Purpose
Our Purpose For personal use only Where we want to be in 2022 Apply Anteo surface technologies to solve important industrial problems and create shareholder value 9
Slide 10: Our Vision
Our Vision For personal use only Where we want to be in 2022 Anteo will be the go-to-provider for innovative surface modification solutions 10
Slide 11: Our Strategic Statement
Our Strategic Statement For personal use only Where we want to be in 2022 We aim to become the leading player in the surface modification technology platform industry by 2022. To do this we shall implement a growth strategy by exploiting our superior ability to innovate, manage our intellectual prop
Slide 12: Internal Goals
Internal Goals For personal use only 1. Implement a Strategic Plan to chart the path to commercial success 2. Ensure an effective, structured, robust business development capability to attain our strategy 3. Assure robust protection of, and succession planning around, our IP/intellectual capital 4.
Slide 13: External Goals
External Goals For personal use only 1. Establish a sustainable profitable revenue stream 2. Commercialise Anteo IP across selected industries 3. Ensure that Anteo participates as a partner high in the value chain 4. Detail the value proposition for our solutions for selected industries 5. Enhance o
Slide 14: Key Initiatives
Key Initiatives For personal use only Next 24 Months o Strategy implementation o Capitalise on our Energy Storage Technology o Optimise the ongoing discussions with potential Life Science partners o Initiate Medical Devices partnerships to develop MedTech applications o Business development enhancem
Slide 15: Anteo Diagnostics Strategic Directions Statement 2018-22
Anteo Diagnostics Strategic Directions Statement For personal use only 2018 - 2022 Our Purpose Our Vision Our Strategy Statement Why we exist and what we do Where we want to be in 2023 The broad means by which we shall achieve our vision To apply the Anteo Anteo will be the go-to- We aim to become t
Slide 16: Board Structure
For personal use only Board Structure Independent Board Review Conducted by 16
Slide 17: Successful Strategy Implementation requires a Skills Based board
For personal use only Successful SuccessfulStrategy Implementation Strategy Implementation requires aa Skills requires SkillsBased Basedboard board Source: Effective Governance 17
Slide 18: Board Competencies – A Structured Process
Board Competencies – A Structured Process For personal use only Utilising A Proven Framework The attributes and competencies enabling individual board members to use their knowledge and Behavioural skills to function well as The essential governance team members and to knowledge and understanding al
Slide 19: Detailed Attributes-not just a tick: eg. Accounting
Detailed Attributes-not just a tick: eg. Accounting • No professional experience in accounting • No understanding of basic accounting concepts including cash flows, assets, inventory, short and long term debt, balance sheets, income types, payroll or similar For personal use only • No practical acco
Slide 20: Overall Board Skills Results
Overall Board Skills Results For personal use only Self Assessment Section Met Not met Industry Experience and Knowledge 5 0 Technical Skills and Experience 10 0 Governance Competencies 7 4 Behavioural Competencies 10 0 Table 1: Competencies held and not held by competency area – current Board only
Slide 21: Anteo Diagnostics Board Skills 2017
Director Anteo Diagnostics Board Skills 2017: Alan Studley John Hurrell Sanderson Cumming Sickman Geoff Matt Rolf Copyright 2017 Effective Governance Pty Ltd. This template has been provided for the exclusive use of Anteo Diagnostics and can not be used further, without permission from Effective Gov
Slide 22: Recommendations
Recommendations For personal use only For Board to undertake The Board collectively reassess the responses from this review to gain agreement on the 1. responses provided and the number of Directors and the competency levels required; The Board review the gaps provided in the detailed results and up
Slide 23: Update on Opportunities
For personal use only Update on Opportunities November 2017 23
Slide 24: What is Anteo Technology? Different Types of Metal-ion Polymers
What is Anteo Technology? - Different Types of Metal-ion Polymers For personal use only A stable coordination surface A stable coordination on any substrate. surface on hydrophobic M M M M substrate. M M M M Binding to any electron donating groups on 2. Substituted metal-ion polymers hydrophilic or
Slide 25: IP Assets: Diagnostics, Medical and Energy
IP Assets: Diagnostics, Medical and Energy For personal use only AP011 “Conductive Composites” Medical Devices Batteries & Energy Controlled Release of small molecules. Protecting Materials, swelling/shrinking, AP008 “Controlled Competitive partial solublization. Exchange” AP009 “Composition” Key Bi
Slide 26: Opportunities & Market Focus
Opportunities & Market Focus For personal use only 2018 and Beyond • Si Anodes • Infectious Total market = • Cathodes diseases • Binders • Chronic Total market $6bn Diseases > $2.5bn Point of Energy Care (PoC) AnteoCoat AnteoBind In Vitro Diagnostics Medtech AnteoRelease AnteoBind Total market • IVD
Slide 27: Energy
For personal use only ENERGY 27
Slide 28: Energy: Demand, Problem and Unmet Need
Energy: Demand, Problem and Unmet Need For personal use only o The battery industry is in demand for low cost, high capacity, fast charging batteries with long cycle lives for automotive, consumer and industrial applications. o Problem: New active high energy anode and cathode battery materials coul
Slide 29: Anteo Technology Potential in Battery Field
Anteo Technology Potential in Battery Field For personal use only o External evaluation on Anteo Technology by Polaris Battery Labs in USA was very positive. Not all questions answered yet. o Presently only focused on the Silicon Anode and Anode Binders o Very early data and theoretical consideratio
Slide 30: Improved Structural Integrity with AnteoCoat
Improved Structural Integrity with AnteoCoat For personal use only Initial tests indicate AnteoCoat: o provides strong bonds between silicon and binder which enhances structural integrity. o still maintains structural integrity even after many hundreds of deep charge/discharge cycles and improves ba
Slide 31: Strong Adhesion with AnteoCoat
Strong Adhesion with AnteoCoat For personal use only o Photographs of silicon based anodes after 1000 deep charge/discharge cycles. o Without inclusion of AnteoCoat (Left) there is cracking and the anode active material is easily flaking off the copper current collector. With inclusion of AnteoCoat
Slide 32: Strong Adhesion with AnteoCoat
Strong Adhesion with AnteoCoat For personal use only A) Control (no AnteoCoat) B) With AnteoCoat Photos of a metal complex coated 5-10 um cathode electrode Photo A is the control without AnteoCoat. Picture B is the same material with AnteoCoat. Both half-coin cells were cycled 1,000 times (deep char
Slide 33: Polaris Report Confirmed Progression of AnteoCoat IP
Polaris Report Confirmed Progression of AnteoCoat IP and Continued Development For personal use only o “There are a number of handling and other benefits to Anteo’s Coating solutions that will allow easy adoption to current manufacturing plants. They are as follows; ▪ Work in water or organic solven
Slide 34: Anteo Energy: Market Feedback Provided by Global Companies
Anteo Energy: Market Feedback Provided by Global Companies For personal use only We talked to 75% of global battery cell market = $17bn Anteo’s value is: - Improved cycle life - More energy - Cost? Possible opportunities: Silicon particle coat or binder. 34
Slide 35: Anteo's Addressable Markets: Lithium-ion Battery Value Chain
Anteo‘s Addressable Markets: Lithium-ion Battery Value Chain For personal use only Cathode market: $4.7bn Anode market: $1.16bn Main Anode and cathode markets: o 70% China o 25% Japan 35
Slide 36: Lithium Ion Battery Goals to be developed with Polaris
Lithium Ion Battery Goals to be developed with Polaris For personal use only 2018 o Refine the existing commercial strategy to drive development and define a technology monetization in the near to mid term future. o Test capacity improvement @1000 cycles within 12 months. What is an achievable goal?
Slide 37: Anode Market Projection
Anode Market Projection For personal use only Source: XG Sciences Inc, 2016 37
Slide 38: Lithium Ion Batteries - Environment
Lithium Ion Batteries - Environment For personal use only Samsung’s Electric Vehicle Goals o By 2018: o EV driving range = 500km. o By 2022: o 600km drive range = High Ni cathode and silicon materials in anode – increase Silicon loading. o Samsung believes drive range beyond 750km – post Li ion batt
Slide 39: Li-Ion Energy Capacity Improvement
Li-Ion Energy Capacity Improvement For personal use only Energy capacity improvement direction (Samsung) Samsung Relative energy capacity 30% >750km drive range: 40% Post Li-ion battery: o Lithium air, Lithium metal by 2025-2030. 300km (2017) <500km (2018) >500km (2020) Driving range of compact size
Slide 40: Time to Market for New Lithium Ion Battery Material
Time to Market for New Lithium Ion Battery Material For personal use only Our window of opportunity New competing technologies: o Lithium air by 2030. 40
Slide 41: Critical Success Factors
Critical Success Factors For personal use only o External: o Government subsidies (China) o Global economy and oil price o Competition to improve efficiency cost effectively o Strong cost and safety pressure in industry o Internal: o Refined commercialization plan o Understand the working mechanism
Slide 42: Point of Care
For personal use only POINT OF CARE 42
Slide 43: Point of Care
Point of Care For personal use only Main PoC markets: o Blood Glucose, rapid coagulation and cardiac marker testing. 43
Slide 44: Point of Care – Environment and Trends
Point of Care – Environment and Trends For personal use only o Increase in chronic and infectious diseases (e.g. respiratory diseases and Malaria) o New technology trends such as molecular PoC and liquid biopsy o Western hospitals acquire GP clinics. Hospitals are need to network different PoC in GP
Slide 45: PoC - Opportunities
PoC - Opportunities For personal use only o Ellume – Infectious disease Lateral Flow (LFIA) test. o AnteoBind, part of Ellume IP on Quantum Dot detection technology Increase signal sensitivity and lower Limit of Detection (LoD) o Clinical trial results released o Atomo Diagnostics – Discussions on
Slide 46: Key Success Factors
Key Success Factors For personal use only o External: o Partnering at the high end of the value chain o Develop partner with complimentary skills e.g. market knowledge and presence, distribution channels o Build solid business case to define: o The need in detail o Distribution channels o Reimbursem
Slide 47: PoC: Next Steps
PoC: Next Steps For personal use only o Leverage existing R&D projects and IP to form partnerships to develop products with Anteo being a full partner rather than a service/component provider o Expand on existing PoC commercilisation strategy and generate business case for the first potential partne
Slide 48: In Vitro Diagnostics
For personal use only IN VITRO DIAGNOSTICS 48
Slide 49: In-Vitro Diagnostics (IVD)
In-Vitro Diagnostics (IVD) For personal use only 49
Slide 50: IVD – Update/Opportunities
IVD – Update/Opportunities For personal use only o In final stages of negotiation with a large diversified Lifesciences/Healthcare company in China to distribute Anteo reagents into the Chinese IVD market o Develop a business case driven plan to expand Anteo’s IVD reagents revenue stream through exi
Slide 51: Life Science and IVD
Life Science and IVD For personal use only o Increase in chronic and infectious diseases as well as cancer. Early detection and screening of cancers for oncology drug development. o Hospital consilidation asks for automated, fast, accurate and low cost diagnsotic tests. o Combination of diagnostic t
Slide 52: Critical Success Factors
Critical Success Factors For personal use only o External: o Government regulation o Reimbursement o Competition o Internal: o Expand existing assay development capabilities o Strengthen the business development capability within the company 52
Slide 53: MedTech Opportunities
For personal use only MedTech Opportunities 53
Slide 54: Medical Devices
For personal use only Medical Devices 54
Slide 55: Medical Devices – Future Areas of Focus
Medical Devices – Future Areas of Focus For personal use only 55
Slide 56: Potential Opportunities
Potential Opportunities For personal use only Orthopedic implants Dental implants > 29 bn market > $4 bn market AnteoRelease Cochlear implants Cardiology $3 bn market (e.g. cathethers, stents) > 10 bn market 56
Slide 57: Critical Success Factors (Early Stage Opportunity Analysis)
Critical Success Factors (Early Stage Opportunity Analysis) For personal use only o External: o Government regulation o Reimbursement o Competitive technologies o Internal: o Resources: lack of skilled and experienced medical device development expertise o Leverage – Control? (Partnering/JV opportun
Slide 58: Summary
Summary For personal use only o We have started down a bright new path with a new broad Vision: To be the go-to-provider for innovative surface modification solutions o We now need dedication to the vision and a stable and positive environment to allow the company to thrive along the direction defin
Anteo Diagnostics — Investor Presentation (November 2017) on 6ix